Concepedia

Publication | Open Access

Exposure to Rifampicin Is Strongly Reduced in Patients with Tuberculosis and Type 2 Diabetes

DOIFull Paper Access

239

Citations

18

References

2006

Year

Hanneke M. J. Nijland, Rovina Ruslami, Janneke E. Stalenhoef, Erni Juwita Nelwan, Bachti Alisjahbana, R.H.H. Nelwan, André van der Ven, Halim Danusantoso, Rob E. Aarnoutse, Reinout van Crevel
Clinical Infectious Diseases

Abstract

Exposure (AUC(0-6 h)) to rifampicin was 53% lower in Indonesian patients with TB and DM, compared with patients with TB only. Patients with TB and DM who have a higher body weight may need a higher dose of rifampicin.

References

YearCitations

Page 1